HRP970615B1 - Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation - Google Patents

Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation

Info

Publication number
HRP970615B1
HRP970615B1 HR970615A HRP970615A HRP970615B1 HR P970615 B1 HRP970615 B1 HR P970615B1 HR 970615 A HR970615 A HR 970615A HR P970615 A HRP970615 A HR P970615A HR P970615 B1 HRP970615 B1 HR P970615B1
Authority
HR
Croatia
Prior art keywords
dalfopristine
quinupristine
preparation
base
pharmaceutical compositions
Prior art date
Application number
HR970615A
Other languages
English (en)
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP970615A2 publication Critical patent/HRP970615A2/hr
Publication of HRP970615B1 publication Critical patent/HRP970615B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR970615A 1996-11-19 1997-11-17 Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation HRP970615B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (2)

Publication Number Publication Date
HRP970615A2 HRP970615A2 (en) 1998-08-31
HRP970615B1 true HRP970615B1 (en) 2002-12-31

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970615A HRP970615B1 (en) 1996-11-19 1997-11-17 Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation

Country Status (45)

Country Link
US (1) US5994338A (no)
EP (1) EP0949923B1 (no)
JP (1) JP4278115B2 (no)
KR (1) KR100530836B1 (no)
CN (1) CN1146417C (no)
AP (1) AP998A (no)
AR (1) AR008695A1 (no)
AT (1) ATE223217T1 (no)
AU (1) AU740291B2 (no)
BG (1) BG63621B1 (no)
BR (1) BR9713087A (no)
CA (1) CA2271095C (no)
CO (1) CO4910113A1 (no)
CZ (1) CZ299913B6 (no)
DE (1) DE69715247T2 (no)
DK (1) DK0949923T3 (no)
DZ (1) DZ2349A1 (no)
EA (1) EA002025B1 (no)
EE (1) EE03668B1 (no)
ES (1) ES2179375T3 (no)
FR (1) FR2755857B1 (no)
HK (1) HK1022832A1 (no)
HR (1) HRP970615B1 (no)
HU (1) HUP9904327A3 (no)
IL (2) IL129607A0 (no)
IN (1) IN187038B (no)
JO (1) JO1992B1 (no)
MA (1) MA26448A1 (no)
MY (1) MY123805A (no)
NO (1) NO992399D0 (no)
NZ (1) NZ334949A (no)
OA (1) OA11047A (no)
PE (1) PE13999A1 (no)
PL (1) PL190164B1 (no)
PT (1) PT949923E (no)
RS (1) RS49608B (no)
SA (1) SA97180645B1 (no)
SK (1) SK284311B6 (no)
TN (1) TNSN97184A1 (no)
TR (1) TR199901096T2 (no)
TW (1) TW474816B (no)
UA (1) UA59376C2 (no)
UY (1) UY24780A1 (no)
WO (1) WO1998022107A1 (no)
ZA (1) ZA9710435B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
HU230656B1 (hu) 1998-09-25 2017-06-28 Cubist Pharmaceuticals Llc Daptomicin alkalmazása
AU776782C (en) * 1999-03-03 2005-04-07 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
YU22499A (sh) 2002-03-18
ES2179375T3 (es) 2003-01-16
FR2755857B1 (fr) 1998-12-24
EE9900127A (et) 1999-12-15
CZ299913B6 (cs) 2008-12-29
EA199900479A1 (ru) 2000-02-28
HUP9904327A2 (hu) 2000-06-28
PL190164B1 (pl) 2005-11-30
EE03668B1 (et) 2002-04-15
KR100530836B1 (ko) 2005-11-23
PT949923E (pt) 2003-01-31
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
HK1022832A1 (en) 2000-08-25
BG103412A (en) 2000-06-30
MA26448A1 (fr) 2004-12-20
HUP9904327A3 (en) 2002-03-28
HRP970615A2 (en) 1998-08-31
EA002025B1 (ru) 2001-12-24
UY24780A1 (es) 2001-08-27
CA2271095A1 (fr) 1998-05-28
IN187038B (no) 2001-12-29
AP998A (en) 2001-08-09
MY123805A (en) 2006-06-30
CN1233959A (zh) 1999-11-03
CN1146417C (zh) 2004-04-21
AU740291B2 (en) 2001-11-01
PE13999A1 (es) 1999-05-05
DK0949923T3 (da) 2002-12-23
BG63621B1 (bg) 2002-07-31
US5994338A (en) 1999-11-30
SK284311B6 (sk) 2005-01-03
WO1998022107A1 (fr) 1998-05-28
IL129607A (en) 2006-08-20
DE69715247T2 (de) 2003-04-30
TW474816B (en) 2002-02-01
AR008695A1 (es) 2000-02-09
NO992399L (no) 1999-05-19
EP0949923B1 (fr) 2002-09-04
DZ2349A1 (fr) 2002-12-28
JO1992B1 (en) 1999-05-15
JP2001504475A (ja) 2001-04-03
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
JP4278115B2 (ja) 2009-06-10
BR9713087A (pt) 2000-03-28
RS49608B (sr) 2007-06-04
SK66099A3 (en) 2000-01-18
NO992399D0 (no) 1999-05-19
KR20000053343A (ko) 2000-08-25
ATE223217T1 (de) 2002-09-15
NZ334949A (en) 2000-12-22
CZ174899A3 (cs) 1999-08-11
TNSN97184A1 (fr) 2005-03-15
IL129607A0 (en) 2000-02-29
OA11047A (fr) 2003-03-07
DE69715247D1 (de) 2002-10-10
ZA9710435B (en) 1998-06-10
CA2271095C (fr) 2004-08-03
TR199901096T2 (xx) 1999-07-21
AU5125698A (en) 1998-06-10
EP0949923A1 (fr) 1999-10-20

Similar Documents

Publication Publication Date Title
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL119995A0 (en) Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
HUP0101130A3 (en) Aminoindan derivatives and pharmaceutical compositions comprising them
IL120902A0 (en) Interferon conjugates their preparation and pharmaceutical compositions containing them
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
HUP0000733A3 (en) Aminoguanidines and alkoxyguanidines as and pharmaceutical compositions containing them
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
EP0960885A4 (en) DEPSIPEPTIDES AND MEDICATIONS, WHICH CONTAIN THE SAME AS ACTIVE INGREDIENCIES
EP0757910A4 (en) BASIC COMPOSITION ADMINISTERED BY PERCUTANEOUS ROUTE AND DRUG COMPOSITION ADMINISTERED BY PERCUTANEOUS ROUTE OBTAINED FROM THE SAME
HK1040165B (zh) 營養和藥物組合物
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
IL140742A0 (en) Raloxifene and pharmaceutical composition comprising the same
ZA9811470B (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
HRP970615B1 (en) Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation
IL125908A (en) Peptides and pharmaceutical compositions comprising same
IL120637A0 (en) Retinoids their preparation and pharmaceutical compositions containing them
PL328334A1 (en) Preparation and application thereof
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: AVENTIS PHARMA S.A., FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20061005

Year of fee payment: 10

PBON Lapse due to non-payment of renewal fee

Effective date: 20071118